BREAKING
Home » Posts Tagged "NIH"

NIH: Universal Flu Vaccine, FluMos-v2, designed to target 6 flu strains begins clinical trials

By

NewsDesk @bactiman63 Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland....

AstraZeneca vaccine prevents COVID-19 according to results from a large clinical trial

By

Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease,...

NIH changes on use of ivermectin for treatment of COVID-19

By

By News Desk  @bactiman63 In August 2020, the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel firmly said of the use of ivermectin: The COVID-19 Treatment Guidelines Panel recommends...

COVID-19 combo treatment tested in NIH clinical trial

By

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated...

COVID-19 treatment: NIH study aims to determine safety and efficacy of experimental monoclonal antibodies

By

Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized,...

Experimental COVID-19 Vaccine Protects Upper and Lower Airways in Nonhuman Primates

By

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19)  induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques...

NIH: Investigational COVID-19 vaccine generally well tolerated and prompted neutralizing antibody activity

By

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody...

COVID-19 investigational vaccine: Clinical trials begin in Seattle

By

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI)...

CDC, NIH report COVID-19 positive employees

By

By NewsDesk  @infectiousdiseasenews The Centers for Disease Control and Prevention (CDC) today confirmed the first case of 2019 novel coronavirus disease (COVID-2019) in a CDC employee. Laboratory testing...

generic influenza virion

Universal Flu Vaccine Candidate: Osivax Enters Agreement with NIH to test

By

Osivax announced Thursday that it has entered into an agreement with the United States’ National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH),...